Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 337

1.

Advances in Universal Influenza Virus Vaccine Design and Antibody Mediated Therapies Based on Conserved Regions of the Hemagglutinin.

Krammer F, Palese P, Steel J.

Curr Top Microbiol Immunol. 2014 Jul 10. [Epub ahead of print]

PMID:
25007847
[PubMed - as supplied by publisher]
2.

Peering into the crystal ball: influenza pandemics and vaccine efficacy.

Miller MS, Palese P.

Cell. 2014 Apr 10;157(2):294-9. doi: 10.1016/j.cell.2014.03.023.

PMID:
24725400
[PubMed - indexed for MEDLINE]
3.

Localized oncolytic virotherapy overcomes systemic tumor resistance to immune checkpoint blockade immunotherapy.

Zamarin D, Holmgaard RB, Subudhi SK, Park JS, Mansour M, Palese P, Merghoub T, Wolchok JD, Allison JP.

Sci Transl Med. 2014 Mar 5;6(226):226ra32. doi: 10.1126/scitranslmed.3008095.

PMID:
24598590
[PubMed - in process]
4.

Divergent H7 immunogens offer protection from H7N9 virus challenge.

Krammer F, Albrecht RA, Tan GS, Margine I, Hai R, Schmolke M, Runstadler J, Andrews SF, Wilson PC, Cox RJ, Treanor JJ, García-Sastre A, Palese P.

J Virol. 2014 Apr;88(8):3976-85. doi: 10.1128/JVI.03095-13. Epub 2014 Jan 22.

PMID:
24453375
[PubMed - indexed for MEDLINE]
5.

Broadly neutralizing hemagglutinin stalk-specific antibodies require FcγR interactions for protection against influenza virus in vivo.

DiLillo DJ, Tan GS, Palese P, Ravetch JV.

Nat Med. 2014 Feb;20(2):143-51. doi: 10.1038/nm.3443. Epub 2014 Jan 12.

PMID:
24412922
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Assessment of influenza virus hemagglutinin stalk-based immunity in ferrets.

Krammer F, Hai R, Yondola M, Tan GS, Leyva-Grado VH, Ryder AB, Miller MS, Rose JK, Palese P, García-Sastre A, Albrecht RA.

J Virol. 2014 Mar;88(6):3432-42. doi: 10.1128/JVI.03004-13. Epub 2014 Jan 8.

PMID:
24403585
[PubMed - indexed for MEDLINE]
7.

Universal influenza virus vaccines: need for clinical trials.

Krammer F, Palese P.

Nat Immunol. 2014 Jan;15(1):3-5. doi: 10.1038/ni.2761. No abstract available.

PMID:
24352315
[PubMed - indexed for MEDLINE]
8.

Influenza A(H7N9) virus gains neuraminidase inhibitor resistance without loss of in vivo virulence or transmissibility.

Hai R, Schmolke M, Leyva-Grado VH, Thangavel RR, Margine I, Jaffe EL, Krammer F, Solórzano A, García-Sastre A, Palese P, Bouvier NM.

Nat Commun. 2013 Dec 10;4:2854. doi: 10.1038/ncomms3854.

PMID:
24326875
[PubMed - in process]
Free PMC Article
9.

H3 stalk-based chimeric hemagglutinin influenza virus constructs protect mice from H7N9 challenge.

Krammer F, Margine I, Hai R, Flood A, Hirsh A, Tsvetnitsky V, Chen D, Palese P.

J Virol. 2014 Feb;88(4):2340-3. doi: 10.1128/JVI.03183-13. Epub 2013 Dec 4.

PMID:
24307585
[PubMed - indexed for MEDLINE]
10.

Expression of functional recombinant hemagglutinin and neuraminidase proteins from the novel H7N9 influenza virus using the baculovirus expression system.

Margine I, Palese P, Krammer F.

J Vis Exp. 2013 Nov 6;(81):e51112. doi: 10.3791/51112.

PMID:
24300384
[PubMed - indexed for MEDLINE]
11.

Genome-wide mutagenesis of influenza virus reveals unique plasticity of the hemagglutinin and NS1 proteins.

Heaton NS, Sachs D, Chen CJ, Hai R, Palese P.

Proc Natl Acad Sci U S A. 2013 Dec 10;110(50):20248-53. doi: 10.1073/pnas.1320524110. Epub 2013 Nov 25.

PMID:
24277853
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Adjuvants and immunization strategies to induce influenza virus hemagglutinin stalk antibodies.

Goff PH, Eggink D, Seibert CW, Hai R, Martínez-Gil L, Krammer F, Palese P.

PLoS One. 2013 Nov 6;8(11):e79194. doi: 10.1371/journal.pone.0079194. eCollection 2013.

PMID:
24223176
[PubMed - in process]
Free PMC Article
13.

Guiding the immune response against influenza virus hemagglutinin toward the conserved stalk domain by hyperglycosylation of the globular head domain.

Eggink D, Goff PH, Palese P.

J Virol. 2014 Jan;88(1):699-704. doi: 10.1128/JVI.02608-13. Epub 2013 Oct 23.

PMID:
24155380
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Influenza virus hemagglutinin stalk-based antibodies and vaccines.

Krammer F, Palese P.

Curr Opin Virol. 2013 Oct;3(5):521-30. doi: 10.1016/j.coviro.2013.07.007. Epub 2013 Aug 24. Review.

PMID:
23978327
[PubMed - indexed for MEDLINE]
15.

Neutralizing antibodies against previously encountered influenza virus strains increase over time: a longitudinal analysis.

Miller MS, Gardner TJ, Krammer F, Aguado LC, Tortorella D, Basler CF, Palese P.

Sci Transl Med. 2013 Aug 14;5(198):198ra107. doi: 10.1126/scitranslmed.3006637.

PMID:
23946196
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Hemagglutinin stalk-based universal vaccine constructs protect against group 2 influenza A viruses.

Margine I, Krammer F, Hai R, Heaton NS, Tan GS, Andrews SA, Runstadler JA, Wilson PC, Albrecht RA, García-Sastre A, Palese P.

J Virol. 2013 Oct;87(19):10435-46. doi: 10.1128/JVI.01715-13. Epub 2013 Jul 31.

PMID:
23903831
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

A small molecule multi-kinase inhibitor reduces influenza A virus replication by restricting viral RNA synthesis.

Martinez-Gil L, Alamares-Sapuay JG, Ramana Reddy MV, Goff PH, Premkumar Reddy E, Palese P.

Antiviral Res. 2013 Oct;100(1):29-37. doi: 10.1016/j.antiviral.2013.07.010. Epub 2013 Jul 24.

PMID:
23891991
[PubMed - indexed for MEDLINE]
18.

In vivo bioluminescent imaging of influenza a virus infection and characterization of novel cross-protective monoclonal antibodies.

Heaton NS, Leyva-Grado VH, Tan GS, Eggink D, Hai R, Palese P.

J Virol. 2013 Aug;87(15):8272-81. doi: 10.1128/JVI.00969-13. Epub 2013 May 22.

PMID:
23698304
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Induction of cross-reactive antibodies to novel H7N9 influenza virus by recombinant Newcastle disease virus expressing a North American lineage H7 subtype hemagglutinin.

Goff PH, Krammer F, Hai R, Seibert CW, Margine I, García-Sastre A, Palese P.

J Virol. 2013 Jul;87(14):8235-40. doi: 10.1128/JVI.01085-13. Epub 2013 May 22.

PMID:
23698299
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Recombinant IgA is sufficient to prevent influenza virus transmission in guinea pigs.

Seibert CW, Rahmat S, Krause JC, Eggink D, Albrecht RA, Goff PH, Krammer F, Duty JA, Bouvier NM, García-Sastre A, Palese P.

J Virol. 2013 Jul;87(14):7793-804. doi: 10.1128/JVI.00979-13. Epub 2013 May 22.

PMID:
23698296
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk